Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 3401

Exclusive: Cardiometabolic biotech gets $57.5M Series B, with help from Cytokinetics

$
0
0
A biotech incubated by RA Capital has secured a $57.5 million Series B to begin a mid-stage trial for its cardio drug this quarter and get to a readout in late 2026. Imbria Pharmaceuticals has ...

Viewing all articles
Browse latest Browse all 3401

Trending Articles